Argus Research Downgrades Southwest Airlines to Hold

Argus Research analyst John Staszak downgrades Southwest Airlines (NYSE:LUV) from Buy to Hold.

byBenzinga Newsdesk

August 15, 2022

1 minute read

Argus Research analyst John Staszak downgrades Southwest Airlines (NYSE:LUV) from Buy to Hold.

Nio Says Production Back On Track After Hit From China COVID-19 Curbs

By Bhavik Nair

Today, 5:08 PM

Chinese EV-maker Nio Inc (NYSE: NIO) said on Thursday it had resumed production after it was initially affected due to COVID-19 curbs&nbs

NIO

Stanley Black & Decker Q4 EPS $2.14 Beats $2.05 Estimate, Sales $4.10B Miss $4.49B Estimate

By Bill Haddad

Today, 5:08 PM

Stanley Black & Decker (NYSE:SWK) reported quarterly earnings of $2.14 per share which beat the analyst consensus estimate of $2.05 by 4.39 percent. This is a 34.95 percent decrease over earnings of $3.29 per share from

SWK

Eagle Pharmaceuticals Reports That Par Has Unilaterally Withdrawn Attempt To Halt Launch Of Vasopressin

By Benzinga Newsdesk

Today, 5:08 PM

Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) ("Eagle" or the "Company") today announced that Par Pharmaceutical, Inc. ("Par") has unilaterally withdrawn its request that the U.S. District Court

EGLX

XOMA Buys Royalty, Milestone Interest In Checkmate’s Vidutolimod From Kuros Biosciences

By Vandana Singh

Today, 5:08 PM

XOMA Corporation (NASDAQ:XOMA) has acquired the royalty interest position Kuros Biosciences holds in Checkmate Pharmaceuticals Inc’s (NASDAQ:CMPI) vidutolimod (CMP-001), for $7.0 million upfront plus $166.5…

BMY

Argus Research Downgrades Southwest Airlines to Hold

Related Posts

Nio Says Production Back On Track After Hit From China COVID-19 Curbs

Stanley Black & Decker Q4 EPS $2.14 Beats $2.05 Estimate, Sales $4.10B Miss $4.49B Estimate

Eagle Pharmaceuticals Reports That Par Has Unilaterally Withdrawn Attempt To Halt Launch Of Vasopressin

XOMA Buys Royalty, Milestone Interest In Checkmate’s Vidutolimod From Kuros Biosciences